Patent challengers and patent owners now face a split process at the USPTO: three-judge PTAB panels decide the merits of inter partes and post-grant review petitions, while the Director keeps control of discretionary denials. Holland & Hart patent attorney Molly Kocialski, a former USPTO regional office director, told Bloomberg Law and IAM what the change does and doesn’t resolve.
Molly tells Bloomberg Law the change is a “step in the right direction.” “I still don’t think that the agency is being as forthcoming as they need to be,” she said. Discussing the sharp drop in challenges, she notes, “this trend risks upholding weak patents because they’re never challenged.” She adds, “I think the thumb is on the lever not to send these cases to the PTAB. I’m not sure that that’s a good thing for the IP system.” She also says “the agency seems to prioritize some discretionary factors over others at different points in time, and it remains unclear how to ‘navigate the waters of discretionary denial.’”
Molly tells IAM she “welcomes written institution opinions as a step towards greater transparency,” noting “for roughly 18 months, parties have been unsure whether petitions were denied on discretionary grounds or on the merits.”
“When companies spend all the money to prepare an IPR and submit it, it seems like not having any answers is very unsatisfactory, and it’s not just unsatisfactory for the person preparing the IPR request,” Molly said. “It’s also unsatisfactory for the patent owner, because then the patent owner doesn’t know why they won or lost, and it doesn’t help bring the parties together on deciding what should go forward and what shouldn’t.”
Molly also tells IAM that “written opinions from three-judge PTAB merits panels could help parties reassess their positions and encourage settlements,” and she “recalls settlements following institution decisions under the board’s earlier approach.” As she explains, “when you have a decision from the Patent Trial and Appeal Board judges that says, ‘here is what we are thinking about the art that you submitted’, I think that makes both parties actually go back and reassess like, ‘okay, we should settle the IPR. Maybe we should settle the litigation in full.’”
She also “wants the director [Squires] to clarify how discretionary denial factors are weighted,” suggesting that “a flowchart or other guidance could show which factors are considered first and how competing considerations, such as a patent’s age and a company’s US manufacturing activities, are balanced.”
“I still think that there’s more that he could explain to people about what is going on,” Molly said.